Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKBA Ointment in Mild to Moderate Plaque Psoriasis
CTR20220656Phase 2Completed
- Sponsor
- Bochuangyuan Biopharmaceutical
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid in plaque psoriasis, sponsored by Bochuangyuan Biopharmaceutical. Started Mar 2022; status: completed.
02
Drugs
3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20220656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220656.